Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone vs Amiloride in CKD
NCT02497300Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2015
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in chronic kidney disease (CKD), sponsored by University of Alabama at Birmingham. Started Mar 2015; status: completed.
02
Drugs
spironolactone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02497300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497300.